Feds Tightening Dilemma Strong Jobs Data Undermines Case for Rate Cuts SP 500 Recovers as Tech Surge Offsets Energy Rout Dow Slips UK Police Chiefs Push for Social Media Block for Under16s Regulatory Risks for Tech Firms Vestas Wind Systems Shares Decline After Margin Guidance Revised to Low End Indian Bond Bull Market May Pause but Remains Intact Expert Suggests Trump Signals Potential Decision on Iran Nuclear Deal by Sunday Geopolitical Tensions Could Impact Oil Markets VIA Q1 2026 Earnings NarrowerThanExpected Loss Sends Shares Higher WILC Q4 2025 Earnings Solid EPS Despite Absence of Revenue Guidance Stock Dips 336 GWH Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage CPIX Q1 2026 Earnings Net Loss Reported Shares Edge Higher PLPC Q1 2026 Earnings EPS Surges Past Estimates with 1528 Surprise Nutanix NTNX Slips 126 as Shares Approach Critical Support Near 44 Argan Inc AGX Gains 383 Testing Resistance After Strong Momentum Cellyan Biotechnology Faces Resistance at 057 After Recent Decline Generation Income Properties Inc GIPR Plunges 29 to 031 Testing Critical Support Levels Gabelli Utility Trust GUT Faces Modest Decline Consolidates Between Key Support and Resistance Dolby Laboratories DLB Advances 336 Testing Resistance as Bullish Momentum Builds InvenTrust Properties IVT Holds Steady Near 33 as Consolidation Continues Allspring Income Opportunities Fund EAD Holds Steady Near Support Faces Key Resistance TROOPS Inc TROO Slides 343 as Selling Pressure Intensifies LaFayette Acquisition Corp Rights LAFAR Holds Steady at 011 Support and Resistance in Focus Fed Rate Cut Prospects Dim as Jobs Data Signals Sticky Inflation ANDG Q1 2026 Earnings Massive EPS Surprise of 834 Shatters Estimates ArrowMark Financial Corp BANX Q4 2022 Earnings Slight EPS Miss Amid Stable Performance Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline NeoVolta Q1 2026 Earnings Narrower Loss Beats Expectations as Stock Rises DMC Global BOOM Q1 2026 Earnings NarrowerThanExpected Loss Supports Modest Stock Gain CACC Q1 2026 Earnings EPS Slightly Misses Estimates Amid Subprime Auto Lending Environment InspireMD NSPR Q1 2026 Earnings EPS Beat Despite Net Loss Shares Dip 29 AIM ImmunoTech Q1 2026 Earnings EPS Miss Widens as Clinical Pipeline Drives Higher Operating Costs